Clinical Trials Find a Clinical Trial 14 Entries Found Principal Investigator: Matthew  Heeney Department: Hematology/Oncology Protocol Title: COMPREHENSIVE SICKLE CELL CENTERS COLLABORATIVE DATA (C-DATA) PROJECT Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Mark W Kieran Department: Hematology/Oncology Protocol Title: QUANTIFICATION OF PROTEINS THAT MEDIATE ANGIOGENESIS IN CHILDREN AND ADULTS Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: GENETIC BASIS OF BLOOD DISEASE Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: THALASSEMIA DATA AND BLOOD SPECIMEN COLLECTION SYSTEM Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: HEMOPHILIA AND THROMBOSIS RESEARCH SOCIETY REGISTRY Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: RANDOMIZED, ACTIVE-CONTROLLED, DOUBLE-BLIND, PARALLEL DESIGN STUDY TO EVALUATE THE EFFICACY AND SAFETY OF A ONCE-A-WEEK PROPHYLAXIS TREATMENT WITH BAY 79-4980 COMPARED TO THREE TIMES-PER WEEK PROPHYLAXIS WITH RFVIII-FS IN PREVIOUSLY TREATED PATIENTS WITH SEVERE HEMOPHILIA A Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: PATHOPHYSIOLOGY OF GENETIC BLOOD DISEASES Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: GENETIC MODIFIERS OF CHILDHOOD CHRONIC IMMUNE THROMBOCYTOPENIC PURPURA (ITP) Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: ITP SPLENECTOMY REGISTRY: PROSPECTIVE, MULTI-CENTER INTERNATIONAL STUDY ON BEHALF OF THE INTERCONTINENTAL CHILDHOOD ITP STUDY (ICIS) GROUP Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: RITUXIMAB FOR THE TREATMENT OF PATIENTS WITH CONGENITAL HEMOPHILIA A AND HIGH TITER INHIBITORS Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: A MULTI-CENTRE, RANDOMISED, DOUBLE-BLINDED, CONTROLLED, DOSE-ESCALATION TRIAL ON SAFETY AND EFFICACY OF ACTIVATED RECOMBINANT FVII ANALOGUE (NN1731) IN THE TREATMENT OF JOINT BLEEDS IN CONGENITAL HAEMOPHILIA PATIENTS WITH INHIBITORS Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis  Neufeld Department: Hematology/Oncology Protocol Title: NORTH AMERICAN CHRONIC ITP REGISTRY Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis  Neufeld Department: Hematology/Oncology Protocol Title: AN INTERNATIONAL, RANDOMIZED, CONTROLLED TRIAL OF IMMUNE-TOLERANCE INDUCTION Protocol Status: Open for Recruitment Trial Description:   Principal Investigator: Ellis J Neufeld Department: Hematology/Oncology Protocol Title: UNIVERSAL DATA AND SERUM SPECIMEN COLLECTION SYSTEM FOR HEMOPHILIA Protocol Status: Open for Recruitment Trial Description:   Clinical Research Previously Conducted at Children's Hospital, Completed. 2 Entries Found Principal Investigator: Matthew  Heeney Department: Hematology/Oncology Protocol Title: A RANDOMIZED, OPEN-LABEL, MULTI-CENTER, PHASE II STUDY TO EVALUATE THE SAFETY AND EFFICACY OF ORAL ICL670 (DEFERASIROX) 20 MG/KG/DAY RELATIVE TO SUBCUTANEOUS DEFEROXAMINE IN SICKLE CELL DISEASE PATIENTS WITH IRON OVERLOAD FROM REPEATED BLOOD TRANSFUSIONS Protocol Status: Recruitment Complete Trial Description:   Principal Investigator: Ellis  Neufeld Department: Hematology/Oncology Protocol Title: PHASE II, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TIRAL COMPARING THE EFFECT OF DEFEROXAMINE WITH OR WITHOUT ORAL DEFERIPRONE (L1) ON CARDIAC LEFT VENTRICULAR FUNCTION ASSESSED BY MRI IN ADULTS WITH TRANSFUSION DEPENDENT BETA THALASSEMIA Protocol Status: Recruitment Complete Trial Description:   Copyright © 2009 Children's Hospital Boston